Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivo
Authors:
Open Access
- 15 February 2023
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 101 (3) , 295-310
Abstract
Pancreas ductal adenocarcinoma (PDAC) remains a malignant tumor with very poor prognosis and low 5-year overall survival. Here, we aimed to simultaneously target mitochondria and lysosomes as a new treatment paradigm of malignant pancreas cancer in vitro and in vivo. We demonstrate that the clinically used sphingosine analog FTY-720 together with PAPTP, an inhibitor of mitochondrial Kv1.3, induce death of pancreas cancer cells in vitro and in vivo. The combination of both drugs results in a marked inhibition of the acid sphingomyelinase and accumulation of cellular sphingomyelin in vitro and in vivo in orthotopic and flank pancreas cancers. Mechanistically, PAPTP and FTY-720 cause a disruption of both mitochondria and lysosomes, an alteration of mitochondrial bioenergetics and accumulation of cytoplasmic Ca2+, events that collectively mediate cell death. Our findings point to an unexpected cross-talk between lysosomes and mitochondria mediated by sphingolipid metabolism. We show that the combination of PAPTP and FTY-720 induces massive death of pancreas cancer cells, thereby leading to a substantially delayed and reduced PDAC growth in vivo. Key messages: FTY-720 inhibits acid sphingomyelinase in pancreas cancer cells (PDAC). FTY-720 induces sphingomyelin accumulation and lysosomal dysfunction. The mitochondrial Kv1.3 inhibitor PAPTP disrupts mitochondrial functions. PAPTP and FTY-720 synergistically kill PDAC in vitro. The combination of FTY-720 and PAPTP greatly delays PDAC growth in vivo.Keywords
Funding Information
- World Cancer Research Fund (22-0348)
- Worldwide Cancer Research (22-0348)
- Universitätsklinikum Essen
This publication has 38 references indexed in Scilit:
- The voltage-dependent K+ channels Kv1.3 and Kv1.5 in human cancerFrontiers in Physiology, 2013
- Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak‐independent death of cancer cellsEMBO Molecular Medicine, 2012
- Gilenya (FTY720) inhibits acid sphingomyelinase by a mechanism similar to tricyclic antidepressantsBiochemical and Biophysical Research Communications, 2011
- Single-point mutations of a lysine residue change function of Bax and Bcl-xL expressed in Bax- and Bak-less mouse embryonic fibroblasts: novel insights into the molecular mechanisms of Bax-induced apoptosisCell Death & Differentiation, 2010
- Connecting Hsp70, sphingolipid metabolism and lysosomal stabilityCell Cycle, 2010
- Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathologyNature, 2010
- The functional network of ion channels in T lymphocytesImmunological Reviews, 2009
- Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytesProceedings of the National Academy of Sciences of the United States of America, 2008
- CD95 Signaling via Ceramide-rich Membrane RaftsJournal of Biological Chemistry, 2001
- Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pHJournal of Biological Chemistry, 1998